|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02628 CHINA LIFE
Nominal 
14.300 -0.160 (-1.107%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Insurance Revenue | 212,445,000 | 16.358% | 182,578,000 | -- | -- | -- |
| Interest Income | 122,994,000 | -- | -- | -- | -- | -- |
| Turnover | -- | -- | -- | -- | -- | -- |
| Gross Premium Income | -- | -- | -- | 618,327,000 | 612,265,000 | 567,086,000 |
| Net Premium Income | -- | -- | -- | 611,251,000 | 604,666,000 | 560,278,000 |
| Investment Income/(Loss) | (9,375,000) | -- | 174,809,000 | 178,387,000 | 154,497,000 | 139,919,000 |
| Net Realised Gains/(Losses) on Assets | -- | -- | -- | 20,344,000 | 14,583,000 | 1,831,000 |
| Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | 4,943,000 | 21,900,000 | 19,251,000 |
| Other Income/(Loss) | 10,603,000 | 11.669% | 9,495,000 | 10,005,000 | 9,403,000 | 8,195,000 |
| Total Revenues | 336,667,000 | -8.236% | 366,882,000 | 824,930,000 | 805,049,000 | 729,474,000 |
| Insurance Service Expenses | (150,353,000) | 14.238% | (131,614,000) | -- | -- | -- |
| Net Expenses from Reinsurance Contracts | (288,000) | -- | 2,155,000 | -- | -- | -- |
| Net Finance (Expenses)/Income from Insurance Contracts | (127,923,000) | -13.972% | (148,700,000) | -- | -- | -- |
| Net Finance (Expenses)/Income from Reinsurance Contracts | 616,000 | 5.660% | 583,000 | -- | -- | -- |
| Net Impairment Loss | 1,217,000 | -- | (3,150,000) | -- | -- | -- |
| Other Expenses | (23,439,000) | 16.757% | (20,075,000) | (784,763,000) | (758,239,000) | (677,690,000) |
| Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
| Share of results of Associates & JCEs | 8,079,000 | 103.041% | 3,979,000 | 10,328,000 | 7,666,000 | 8,011,000 |
| Profit / (Loss) before Taxation | 44,576,000 | -36.375% | 70,060,000 | 50,495,000 | 54,476,000 | 59,795,000 |
| Taxation | 2,971,000 | -- | (1,948,000) | 1,917,000 | (3,103,000) | (781,000) |
| Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
| Non-controlling Interests | (1,366,000) | -4.609% | (1,432,000) | (1,491,000) | (1,116,000) | (727,000) |
| Others | -- | -- | -- | -- | -- | -- |
| Profit/ (Loss) Attributable to Shareholders | 46,181,000 | -30.742% | 66,680,000 | 50,921,000 | 50,257,000 | 58,287,000 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Depreciation & Amortisation | 5,016,000 | -5.198% | 5,291,000 | 5,287,000 | 5,162,000 | 4,379,000 |
| Directors' Emoluments | 2,232 | -66.489% | 6,661 | 4,943 | 3,260 | 3,730 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 163.000 | -30.932% | 236.000 | 180.000 | 177.000 | 205.000 |
| DPS (cts) | 43.000 | -- | 49.000 | 65.000 | 64.000 | 73.000 |
| Dividend Payout Ratio (%) | 26.380% | -- | 20.763% | 36.111% | 36.158% | 35.610% |
| Cash flow per share ($) | 13.599 | -- | 12.216 | 10.134 | 10.756 | 10.120 |
| NBV per share ($) | 16.879 | -- | 12.950 | 16.949 | 15.923 | 14.285 |
| Remarks: | Real time quote last updated: 25/11/2024 16:45 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 38,278,000,000 |
| %Change | 5.884% |
| EPS / (LPS) | RMB 1.350 |
| NBV Per Share (¥) | RMB 17.472 |